DCW Limited Q2 FY27 Earnings Call Transcript Released
DCW Limited released its Q2/H1 FY27 earnings call transcript. The company reported Q2 FY27 revenue of Rs. 663 crore (23% YoY growth) and EBITDA of Rs. 55 crore. H1 FY27 revenue was Rs. 1,205 crore. Management discussed industry challenges and growth investments, including a Rs. 250 crore program and a Rs. 40 crore share buyback.
The announcement provides a detailed update on the company's financial performance, strategic initiatives like investments and share buyback, and outlook. This information is material for investors assessing the company's current standing and future prospects.
The announcement is a transcript of an earnings call. While it details financial performance and future plans, it also highlights industry challenges and pressures, leading to a neutral sentiment as it presents both positive and negative aspects.
DCW Limited has released the transcript of its Earnings Conference Call held on October 30, 2026, to discuss the unaudited financial results for Q2 and H1 FY27. The call featured management including Mr. Saatvik Jain (President), Mr. Sudarshan Ganapathy (CEO), and Mr. Pradipto Mukherjee (CFO).
During the call, management discussed the challenging industry environment due to volatile crude oil and energy prices, impacting feedstock costs and supply chains. Despite these headwinds, DCW's Basic Chemicals profitability improved sequentially, driven by a recovery in PVC. Specialty Chemicals experienced near-term margin pressures, particularly in CPVC, due to input cost increases not immediately reflected in selling prices and higher ocean freight impacting Pigments exports.
The company highlighted its strengthening balance sheet with a Net Debt to EBITDA of 0.12x and a sequential decline in finance costs, expecting a full-year reduction of approximately 10%. FY27 is marked as a turning point for investment in growth, with a Rs. 250 crore investment program initiated for the iron oxide Pigments Business expansion and captive power infrastructure optimization.
DCW's board also approved a share buyback of up to Rs. 40 crores, aimed at enhancing shareholder value without compromising growth investments. The company unveiled a refreshed identity reflecting its mission to harness chemistry for product innovation and its vision to be a global leader powered by innovation and sustainability.
Financially, for Q2 FY27, revenue from operations grew by 23% year-on-year to Rs. 663 crores, with Specialty Chemicals up 32% and Basic Chemicals up 20%. EBITDA, including other income, was Rs. 55 crores, a 32% sequential growth. For H1 FY27, revenue was Rs. 1,205 crores (19% YoY growth), and EBITDA was Rs. 96 crores (20% contraction), impacted by non-recurring events like the West Asia crisis and floods in Gujarat.
Management addressed investor queries regarding PVC-VCM spreads, CPVC pricing, import duties, tax rates, capacity utilization, and power costs. They confirmed a shift to the 25% tax bracket and provided insights into the utilization of various divisions. The company expects the second half of FY27 to be significantly stronger than the first.
What to do with a filing like this
DCW Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by DCW Limited. Read the original for the full detail.